Durvalumab consolidates treatment breakthroughs: Significantly prolongs the survival of confined small cell lung cancer 26/09/2025
Trodvy® received a positive opinion from CHMP for the treatment of HR+/HER2-metastatic breast cancer 12/07/2023
Application of Talazoparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene changes 21/06/2022 prostate cancer
Tipifarnib is used in patients with advanced HRAS mutant head and neck cancer and high mutant allele frequency 20/06/2022 Head and neck cancer HRAS gene
Longest survival data for breast cancer! Kisqali (Ribociclib) requires over 4 years of delayed chemotherapy. 20/06/2022 breast cancer HER2 gene
The overall survival of breast cancer has benefited significantly! Ribociclib's latest test data released 08/06/2022 breast cancer HR
The overall survival of breast cancer has benefited significantly! Ribociclib's latest test data released 08/06/2022 breast cancer HER2
